Christian Behrenbruch, Director at Amplia Therapeutics Ltd., holds 23.23M shares in Telix Pharmaceuticals Ltd. (Ticker: TLPPF), holds 2.74M shares in Amplia Therapeutics Ltd. (Ticker: INNMF).
What is the percentage of profitable transactions made by Christian Behrenbruch?
The percentage of profitable transactions made by Christian Behrenbruch is 50%.
What is the average return per transaction made by Christian Behrenbruch?
The average return per transaction made by Christian Behrenbruch is 66.10%.
What stocks does Christian Behrenbruch hold?
Christian Behrenbruch holds: INNMF, TLPPF stocks.
What was Christian Behrenbruch’s latest transaction?
Christian Behrenbruch latest transaction was an Uninformative Sell of ―.
What was Christian Behrenbruch's most profitable transaction?
Christian Behrenbruch’s most profitable transaction was an Informative Buy of INNMF stock on September 17, 2019. The return on the trade was 133.30%.
What is Christian Behrenbruch's role in Amplia Therapeutics Ltd.?
Christian Behrenbruch's role in Amplia Therapeutics Ltd. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.